Life Insurance
Consensus Index

AI Consensus Fit Review

John Hancock Indexed Universal Life Insurance Fit Review for $2 Million or More in Coverage

John Hancock is a good, but not conclusively best, fit for a healthy high-income buyer seeking $2 million or more of indexed universal life coverage.

Research: 2026-09-217 usable platform responsesRead the methodology ↗

Share

Answer Capsule

John Hancock is a good, but not conclusively best, fit for a healthy high-income buyer seeking $2 million or more of indexed universal life coverage. Six of the seven included platforms named John Hancock during ranking discovery, and all six returned a usable fit assessment. The strongest reason to consider it is a relevant IUL lineup — Accumulation IUL, Protection IUL, and survivorship versions — backed by an A+ Superior AM Best rating and accelerated underwriting advertised up to $5 million. The main limitation is that no public source verified policy-specific pricing, current cap and participation rates, or large-face underwriting performance for a $2 million-plus case.

Research Snapshot

FieldFinding
Platform mentions in ranking stage6 of 7 included platforms (anthropic, deepseek, google, kimi, openai, perplexity)
Share of included platform responses85.7%
Average listed rank5.67
Best listed rank3 (perplexity)
Relevant product/model/planAccumulation IUL; Protection IUL; Accumulation Survivorship IUL for two-life estate planning
Overall use-case fitGood, with material verification required
Research date2026-09-21

Why John Hancock Qualified for This Study

Questions This Section Answers

  • Why did AI platforms recommend John Hancock for $2 million or more of indexed universal life coverage?
  • Is John Hancock a good choice for a healthy high-income buyer who needs a large-face permanent IUL policy?

John Hancock qualified because six of the seven included platforms named it during ranking discovery, and all six returned a usable fit assessment. It cleared the study's two-mention minimum with the third-best single placement among the platforms that ranked it, though its average listed rank of 5.67 reflects that most platforms placed it mid-list rather than first.

The qualification rests on product relevance rather than price leadership. John Hancock markets a named IUL line — Protection IUL and Accumulation IUL for single-life needs, plus survivorship versions for two-life estate planning [1]. Independent reviewers describe indexed universal life as the company's historical stronghold [2]. Third-party rating coverage places the carrier in the upper tier of financial strength, which matters for a contract that may need to perform for 30 or more years [3].

Platform fit ratings were not uniform: grok rated the fit "strong," openai, deepseek, and perplexity rated it "good," and anthropic and kimi rated it "mixed." That spread is itself a finding — the case for John Hancock depends heavily on which objective the buyer prioritizes.

The Product, Model, Plan, or Service Most Relevant to Indexed Universal Life Insurance for $2 Million or More in Coverage

Questions This Section Answers

  • Which John Hancock IUL product should a buyer choose for $2 million or more of coverage?
  • Is John Hancock's Accumulation Survivorship IUL available for two-life estate planning in every state?

The most relevant John Hancock products for this use case are Accumulation IUL and Protection IUL for single-life coverage, and Accumulation Survivorship IUL for two-life estate and legacy planning. John Hancock's own consumer guide describes Protection IUL, Accumulation IUL, Protection Survivorship IUL, and Accumulation Survivorship IUL and their intended protection, accumulation, estate, and legacy uses [4].

Accumulation IUL is positioned for cash-value accumulation and retirement income, using the S&P 500 as its primary index and participating in the Vitality program [5]. Protection IUL is positioned toward death-benefit protection. Accumulation Survivorship IUL launched in late 2025 for trust-owned life insurance and legacy maximization, and independent review coverage states it is available in all states except New York and Guam [7]. John Hancock also markets LifeCare as an indexed universal life product with long-term care benefits [9].

Product naming is a genuine conflict in the evidence. Ranking-stage outputs referenced "Accumulation IUL 26," "Protection IUL 26," and "Accumulation Survivorship IUL 25," while the retrieved public consumer guide uses broader product names without version years [4]. One 2026 distributor notice states that recently launched Accumulation IUL 26 and Protection IUL 26 had no indexed-account parameter changes in that update [10]. Buyers should confirm the exact current policy form and issue version for their state rather than relying on any version label in this review.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about John Hancock for large-face indexed universal life coverage?
  • Does John Hancock have the financial strength and product range for a $2 million IUL policy?

Agreement was strong, though not unanimous, on four points.

Financial strength. Multiple platforms cited upper-tier ratings. AM Best reports an A+ Superior rating with a stable outlook for John Hancock Life Insurance Company (U.S.A.), effective December 12, 2025 [11]. Independent review coverage lists A+ from AM Best, Aa3 from Moody's, AA- from S&P Global, and AA from Fitch, supported by Manulife's $800 billion-plus consolidated asset base [12]. Grok's assessment cited A+ (AM Best), AA- (S&P), A1 (Moody's), and AA (Fitch) [14]. Note that the Moody's letter differs between sources — Aa3 versus A1 — which is a rating-scale notation conflict buyers should confirm directly with the rating agencies.

Product-line relevance. Platforms agreed that John Hancock offers single-life and survivorship IUL designs suited to accumulation, protection, and estate objectives [16].

Indexed crediting structure. John Hancock describes indexed-account and fixed-account allocation with index-linked interest credits subject to caps, floors, participation rates, and multipliers [20]. Independent and company materials describe a 0% floor on indexed-account segment growth, which does not eliminate policy charges or insufficient-premium risk [21].

Underwriting speed. ExpressTrack is described as John Hancock's exam- and lab-free accelerated underwriting approach, with eligibility increased up to $5 million and cycle times reduced, potentially issuing eligible policies in as little as one day [22].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Are John Hancock's IUL policy charges competitive for a $2 million accumulation-focused policy?
  • How much does a John Hancock IUL policy for $2 million or more actually cost?

The sharpest disagreement concerns accumulation competitiveness. One independent review states that in head-to-head illustrations for accumulation-focused clients, Mutual of Omaha (lower internal fees), Securian Financial (superior index options), and Nationwide (higher participation rates) consistently produced better projected outcomes, and that those carriers "have pulled ahead on fee structures, cap rates, and accumulation design" [26]. The same reviewer notes John Hancock "remains a solid carrier with genuine strengths — particularly in underwriting flexibility and the Vitality wellness program — but it's no longer where we place the majority of our IUL business" [28].

Grok reached a different overall conclusion, rating the fit "strong" while still flagging higher policy charges and surrender charges extended to 14 years in Accumulation IUL 26 as a limitation [29]. That is a direct conflict in emphasis: one platform treats charges as a disqualifier for accumulation buyers, another treats them as a trade-off against underwriting and wellness value.

Several items were uncertain across platforms rather than disputed:

  • Pricing. No platform located a public, policy-specific premium or charge schedule for a $2 million-plus case. OpenAI, deepseek, kimi, and perplexity all reported low pricing confidence [30].
  • Current product versions. The exact current issue version among the referenced plan names was not fully verified from retrieved sources [30].
  • Large-face underwriting performance. Public sources do not establish superior jumbo underwriting, maximum face amount, or faster medical underwriting for this coverage level [30].
  • Index option breadth. One review states the index option set is limited primarily to the S&P 500, while competitors offer broader indexes including Nasdaq-100 and volatility-control variants [26]. A 2026 portfolio flyer lists multiple indexed account options with caps and participation rates, which is not the same as independent confirmation of competitiveness [35].
  • Litigation history. One law-firm source cites historical class action litigation involving John Hancock's Performance Universal Life policies [37]. That relates to legacy products, not current IUL offerings, and no active litigation was found.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features does John Hancock's IUL offer for a $2 million estate planning or business succession case?
  • Does John Hancock's Vitality program reduce premiums on a large-face IUL policy?

Death benefit and no-lapse structure. Death benefit options include a level death benefit (Option 1, plus return of premium if elected) or total face amount plus policy value (Option 2) [38]. Public consumer materials indicate John Hancock IUL products include a no-lapse guarantee, with duration extending to age 121 for Protection IUL and Protection SIUL and shorter for Accumulation IUL and Accumulation Survivorship IUL according to those materials [39]. One platform describes a "strong no-lapse guarantee" across all four main IUL products, keeping policies in force even if cash surrender value falls to zero or below, provided minimum premiums are paid [40].

Survivorship design. John Hancock offers four survivorship life insurance options; these cover two lives under a single policy and pay the death benefit upon the second death, which is the structure used for estate planning, wealth transfer, and irrevocable life insurance trust strategies [41]. Accumulation Survivorship IUL is described as delivering cash value accumulation and estate liquidity for trust-owned life insurance [43].

Premium flexibility. Premium payments can be varied based on financial objectives, and a Preliminary Funding Account allows single lump-sum funding with automatic annual transfers at a guaranteed rate during the funding period — potentially useful for buyers with bonus-dependent or irregular income [40].

Vitality wellness integration. Vitality GO is included at no additional cost on eligible policies, and Vitality PLUS may cost as little as $2 per month, with a $4 monthly rider cost stated for survivorship policies; benefits vary by policy and state [44]. John Hancock states Vitality PLUS can provide premium savings of up to 25%, subject to underwriting status, issue age, policy type, policy terms, and achieved Vitality status [45]. One producer guide states Vitality PLUS is $2 per month [46]. Grok's assessment states Vitality credits are available on IUL policies including large face amounts up to $20 million death benefit [47]. These savings are conditional and variable, not guaranteed.

Living benefits. Optional riders include long-term care, critical illness, and estate preservation, with availability and cost varying by policy version and state [48]. LifeCare is marketed as an indexed universal life product with long-term care benefits [49].

Capacity. One independent review states John Hancock offers permanent life insurance coverage ranging from $50,000 to $65 million [50]. Another 2026 review claims permanent coverage can reach very large amounts but that upper limit was not independently verified [51]. Public product materials show Protection IUL with a $50,000 minimum face amount and Accumulation Survivorship IUL with a $250,000 minimum [52].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • What are the policy charges, premium loads, and surrender charges on a John Hancock IUL for $2 million or more?
  • How long do John Hancock IUL surrender charges last, and what happens if the policy lapses?

No verified public premium quote exists for a $2 million-plus John Hancock IUL case. Every platform that addressed pricing reported low confidence, and the company's public guide directs buyers to a licensed agent for costs and complete coverage details [54].

What is documented:

  • Vitality rider costs. Vitality PLUS may cost as little as $2 per month for eligible single-life permanent policies, with $4 per month stated for survivorship policies; these are rider costs, not total insurance premiums [57].
  • Surrender charges. One platform reports surrender charges if the policy lapses within the first 10 years, with historical products showing up to 5.9% of face amount [58]. Another reports surrender charges extended to 14 years in Accumulation IUL 26 [59]. These are conflicting schedules and must be confirmed against the actual contract.
  • Premium loads. Grok's assessment cites premium loads of approximately 7% in year one, lower thereafter, and index performance charges on select accounts such as 0.96% annually on a Nasdaq-linked account [59]. Kimi cites a 5–10% premium load as industry-typical for IUL rather than John Hancock-specific [60].
  • Charge-heavy design. One review characterizes Accumulation IUL 26 as charge-heavy with higher issue and administrative charges, forcing a longer time horizon for efficiency [59].
  • Loan mechanics. Policy loans are described as available after the third policy year on indexed accounts, with segment initiation monthly on the 15th and a lock-in date three business days prior [58]. Loan interest rates were not uniformly disclosed for current products.

Contract terms reported by platforms include coverage available to age 121, no mandatory surrender period but surrender charges in early years, and issuance through licensed advisors and appointed agents only, with no direct online purchase [58]. Public sources reviewed do not establish a specific free-look period, guaranteed premium schedule, or cancellation economics for the requested coverage amount [54].

Best Suited For

Questions This Section Answers

  • Who is John Hancock's IUL best suited for at $2 million or more of coverage?
  • Is John Hancock a good fit for a buyer who wants accelerated underwriting on a large IUL policy?

John Hancock is best suited for buyers whose priorities align with underwriting flexibility, carrier strength, and estate structure rather than lowest projected cash value.

  • Healthy buyers who value accelerated underwriting. ExpressTrack is advertised as exam- and lab-free with eligibility up to $5 million and possible issuance in as little as one day for eligible cases [61].
  • Buyers with complex health profiles. One platform cites flexible underwriting for conditions such as diabetes, family heart history, and tobacco variants [65].
  • Married couples planning estate or legacy transfers. Accumulation Survivorship IUL and Protection Survivorship IUL cover two lives and pay on the second death, which fits ILIT and wealth-transfer strategies [66].
  • Wellness-motivated buyers. Vitality rewards healthy behavior with discounts and rewards, and John Hancock is described as unique for its wellness programs [69].
  • Buyers who prioritize carrier financial strength over lowest cost. Upper-tier ratings support a multi-decade permanent contract [71].
  • Buyers with irregular income. Variable premiums and the Preliminary Funding Account may suit bonus-dependent cash flows [73].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose John Hancock for $2 million or more of indexed universal life coverage?

  • Is John Hancock a poor choice for a buyer who wants the lowest-cost IUL policy?

  • Buyers optimizing pure cash value accumulation. Independent head-to-head illustration work cited by one platform found Mutual of Omaha, Securian Financial, and Nationwide consistently producing better projected outcomes for accumulation-focused clients [74].

  • Buyers who want published pricing before engaging an agent. No public plan-level charge schedule or premium table was located for these products [76].

  • Buyers seeking the lowest guaranteed-cost design. One platform explicitly lists buyers seeking lowest ongoing policy charges and shortest surrender periods as probably not best for this carrier [78].

  • Buyers whose primary objective is guaranteed death benefit. Guaranteed universal life or whole life may fit better when the goal is predictable protection rather than indexed cash-value potential [77].

  • Banking or infinite-banking strategies requiring guaranteed cash value. Whole life from mutual carriers is described as better suited, and John Hancock no longer issues whole life [74].

  • New York residents needing survivorship IUL. Accumulation Survivorship IUL is described as unavailable in New York and Guam [80].

  • Buyers who have not maxed out tax-advantaged retirement accounts. One platform advises maxing 401(k) and IRA contributions first [79].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to John Hancock for a buyer who needs the lowest-cost large-face IUL?
  • When should a buyer choose guaranteed universal life or whole life instead of John Hancock's IUL?

Consider another carrier when a competing illustration shows materially lower policy charges, stronger guarantees, better loan provisions, or more favorable caps and participation rates for the buyer's state and age [81]. Specifically:

  • Maximum accumulation over 20–30 years: Mutual of Omaha, Securian Eclipse Accumulator II, and Nationwide are cited as offering lower fees and higher index participation rates for equivalent risk profiles [82].
  • Broader index flexibility: Securian and Nationwide are described as offering broader index portfolios and volatility control features [82].
  • Guaranteed cash value and predictable loan mechanics: Whole life from mutual carriers such as MassMutual, Northwestern Mutual, and Guardian is described as better suited [82].
  • Lowest illustrated net cost: A broker illustration comparison across multiple carriers may identify a lower-cost carrier for the same face amount [83].
  • Rated or table-rated health profiles: A reinsurer-heavy simplified-issue carrier may price better than John Hancock [83].
  • Guaranteed death benefit with no index variability: Guaranteed universal life or whole life [81].
  • Verified competitive positioning at $2 million-plus: Pacific Life, Prudential, and Principal are named as carriers to compare, though the evidence set did not establish that any of them beats John Hancock for this case [84].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with John Hancock before signing a $2 million IUL contract?
  • How can a buyer verify John Hancock's current IUL charges and index crediting terms?
  1. What is the exact current policy form, issue version, and issuing legal entity for the buyer's state?
  2. Is the requested $2 million or greater face amount available, and what jumbo-case underwriting rules and reinsurance capacity limits apply?
  3. What are the guaranteed and current-assumption values at ages 70, 80, 90, and 100 under multiple premium patterns?
  4. What are the current cap rates, participation rates, floors, multipliers, and indexed-account options, and can the carrier change them?
  5. What are all premium loads, cost-of-insurance charges, administrative charges, rider charges, surrender charges, and loan rates for the illustrated face amount?
  6. What premium is required to keep the policy in force under adverse crediting assumptions, and what is the surrender charge schedule by year?
  7. How do loans and withdrawals affect death benefit, cash value, lapse risk, and possible tax exposure?
  8. Is Vitality GO or Vitality PLUS available for this exact policy and state, and is any quoted savings guaranteed or conditional?
  9. What underwriting timeline, medical requirements, and financial justification apply, and does ExpressTrack apply to this case?
  10. How does the illustration compare with at least two competing IUL or guaranteed-permanent designs using identical assumptions?
  11. For survivorship designs, does the policy support ILIT ownership without additional riders or modifications?
  12. What is the long-term care rider benefit structure — monthly acceleration percentage, maximum duration, and benefit triggers — and its cost at this face amount?

Final AI Consensus Verdict

John Hancock is a good, but not conclusively best, fit for a healthy high-income buyer seeking $2 million or more of indexed universal life coverage. Six of seven included platforms named it during ranking discovery, and all six returned a usable fit assessment, with ratings ranging from "strong" to "mixed."

The case for John Hancock rests on a relevant IUL lineup spanning single-life protection, accumulation, and two-life survivorship designs; upper-tier financial-strength ratings; advertised accelerated underwriting up to $5 million; and a wellness program that is unusual in this category. The case against treating it as the default choice rests on independent illustration evidence that competing carriers produce better projected accumulation outcomes, a charge-heavy design with extended surrender charges in the most recent version, and the complete absence of verified public pricing for a $2 million-plus case.

The evidence is insufficient to call John Hancock the best option for this use case. Large-face underwriting performance, policy charges, guarantees, current product form, and buyer-specific pricing all remain unverified. Buyers should obtain carrier-issued illustrations for the exact face amount and compare guaranteed elements and total costs against at least two competing designs before committing.

How This Review Was Produced

This review was produced from a structured multi-platform research run dated 2026-09-21. Seven AI platforms were configured for the study, and six named John Hancock during ranking discovery and returned a usable fit assessment. Platform fit ratings were: grok "strong"; openai, deepseek, and perplexity "good"; anthropic and kimi "mixed."

Each platform returned a structured fit assessment covering product relevance, financial strength, underwriting, pricing, limitations, and verification questions. Findings were consolidated by factor, and agreement was classified as unanimous, strong, majority, mixed, or limited based on the supplied responses. Citations are platform-reported evidence, not independently verified facts. Company-owned sources are distinguished from independent sources throughout, and the Sources section groups them accordingly.

Methodology Limitations

  • Six of seven included platforms returned a usable fit assessment. Fit findings are not unanimous and should not be described as such.
  • Platform mentions count only platforms that named John Hancock during ranking discovery; this is a discovery metric, not a quality measure.
  • Platform-reported research dates differ from the authoritative run date. Deepseek's assessment is dated 2026-06-01; all other platforms are dated 2026-09-21. Platform-reported dates are provenance metadata and do not independently prove freshness.
  • The supplied URLs were collected from platform responses and were not independently validated at the writing stage.
  • One platform (deepseek) ran without search enabled, so its claims require explicit verification before being treated as current facts.
  • Official-site retrieval failed for the entity during the audit; no failed fetch was used as a verified domain key, and the official website was recovered by web search and verified by site identity rather than direct retrieval.
  • Product naming conflicts were not resolved by guessing. Ranking-stage outputs referenced version years that the retrieved public guide does not confirm.
  • No public, policy-specific pricing or illustration was verified for $2 million or more of coverage. All pricing statements in this review are either rider costs, industry-typical figures, or platform-reported estimates.
  • AI-platform agreement does not prove product quality, claims-paying ability, or suitability for any individual buyer.

See the broader Indexed Universal Life Insurance for $2 Million or More in Coverage consensus index for comparisons across qualified options.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • John Hancock Life Insurance Review (2026): Is It Worth It, and What’s: https://rateschaser.com/life-insurance/reviews/john-hancock-life-insurance-review/
  • Policy crediting rate and indexed account parameter changes: https://www.agencyone.net/wp-content/uploads/2026/02/JHCreditRatingFeb2026.pdf
  • Additional AI research evidence86 records
    1. AI research evidence record openai:c1
    2. AI research evidence record anthropic:40-4
    3. AI research evidence record anthropic:20-1
    4. AI research evidence record openai:c1
    5. AI research evidence record anthropic:8-1
    6. AI research evidence record anthropic:40-5
    7. AI research evidence record anthropic:13-11
    8. AI research evidence record anthropic:42-1
    9. AI research evidence record perplexity:c1
    10. AI research evidence record perplexity:c2
    11. AI research evidence record openai:c3
    12. AI research evidence record anthropic:20-1
    13. AI research evidence record anthropic:21-5
    14. AI research evidence record grok:4
    15. AI research evidence record grok:6
    16. AI research evidence record openai:c1
    17. AI research evidence record anthropic:40-8
    18. AI research evidence record anthropic:40-9
    19. AI research evidence record kimi:fmiagent-jh-iul-2026
    20. AI research evidence record openai:c2
    21. AI research evidence record anthropic:8-3
    22. AI research evidence record anthropic:34-4
    23. AI research evidence record anthropic:34-5
    24. AI research evidence record anthropic:34-6
    25. AI research evidence record perplexity:c11
    26. AI research evidence record anthropic:29-4
    27. AI research evidence record anthropic:29-6
    28. AI research evidence record anthropic:4-3
    29. AI research evidence record grok:2
    30. AI research evidence record openai:c1
    31. AI research evidence record deepseek:jh3
    32. AI research evidence record kimi:moneygeek-iul-rates-2026
    33. AI research evidence record perplexity:c14
    34. AI research evidence record deepseek:jh2
    35. AI research evidence record grok:0
    36. AI research evidence record perplexity:c9
    37. AI research evidence record anthropic:31-8
    38. AI research evidence record anthropic:29-1
    39. AI research evidence record perplexity:c7
    40. AI research evidence record kimi:fmiagent-jh-iul-2026
    41. AI research evidence record anthropic:40-8
    42. AI research evidence record anthropic:40-9
    43. AI research evidence record anthropic:42-1
    44. AI research evidence record openai:c5
    45. AI research evidence record openai:c4
    46. AI research evidence record anthropic:34-1
    47. AI research evidence record grok:13
    48. AI research evidence record anthropic:29-3
    49. AI research evidence record perplexity:c1
    50. AI research evidence record anthropic:1-1
    51. AI research evidence record perplexity:c14
    52. AI research evidence record perplexity:c6
    53. AI research evidence record perplexity:c13
    54. AI research evidence record openai:c1
    55. AI research evidence record deepseek:jh3
    56. AI research evidence record perplexity:c14
    57. AI research evidence record openai:c5
    58. AI research evidence record anthropic:29-4
    59. AI research evidence record grok:2
    60. AI research evidence record kimi:moneygeek-iul-pros-cons
    61. AI research evidence record anthropic:34-4
    62. AI research evidence record anthropic:34-5
    63. AI research evidence record anthropic:34-6
    64. AI research evidence record perplexity:c11
    65. AI research evidence record anthropic:29-4
    66. AI research evidence record anthropic:40-8
    67. AI research evidence record anthropic:40-9
    68. AI research evidence record anthropic:42-1
    69. AI research evidence record anthropic:19-7
    70. AI research evidence record anthropic:19-8
    71. AI research evidence record anthropic:20-1
    72. AI research evidence record openai:c3
    73. AI research evidence record kimi:fmiagent-jh-iul-2026
    74. AI research evidence record anthropic:29-4
    75. AI research evidence record anthropic:29-6
    76. AI research evidence record deepseek:jh3
    77. AI research evidence record openai:c1
    78. AI research evidence record grok:2
    79. AI research evidence record kimi:lifeinsureguide-iul-2026
    80. AI research evidence record anthropic:13-11
    81. AI research evidence record openai:c1
    82. AI research evidence record anthropic:29-4
    83. AI research evidence record deepseek:jh2
    84. AI research evidence record kimi:pacific-life-horizon-2
    85. AI research evidence record kimi:prudential-momentum-iul
    86. AI research evidence record kimi:principal-iul-accumulation-ii

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 21, 2026
Platforms analyzed
7
Source records
35
Ranking mentions
6 of 7
Platform share
86%
Final consensus rank
#6

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

17 independent · 13 company-owned · 5 unclear

Evidence support

19 direct · 16 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

bbd5257b1977e9975adcf68843b8e1fadeff938143f49e7ccc5772f94309e1c7